Omalizumab, mepolizumab, reslizumab i benralizumab per al tractament de l'asma greu no controlada en pacients adults
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess
Digital Resources/Online E-Resources